We investigated whether a potent vasoconstrictor, endothelin, stimulated the proliferation of human thyroid epithelial cells (thyrocytes).
Thyroid tissues from patients with Graves' disease are characterized by pronounced hyperplasia of their thy¬ roid epithelial cells, the generation of new blood vessels and infiltration by mononuclear cells. The neovascularization is shown to depend on the local proliferation of vascular endothelial cells (ECs) . fn an experimental model of thyroid hyperplasia, proliferation of ECs in the small blood vessels preceded hyperplasia of the thyroid follicular cells (1) . Recently we reported that human umbilical vein ECs stimulated the proliferation of human thyroid epithelial cells (2) . The ECs release paracrine factors that include eicosanoids, cyclic nucleotides, endothelium-derived relaxing factor and angiotensin II, which regulate the vasoreactivity and metabolism of the vascular smooth muscle cells (3) (4) (5) (6) . A potent vasocon¬ strictor peptide, endothelin, has been reported to be released by porcine and human ECs (7, 8) . In addition, endothelin-induced vasoconstriction has been shown to be mediated by Ca2+ entry via plasma membrane Ca2 + channels (7) .
We tested whether endothelin stimulates the pro¬ liferation of thyroid epithelial cells (thyrocytes), because many constrictor peptides activate Ca2+ signalling through phospholipase C and induce mitogenesis (9) (10) (11) .
Materials and methods

Preparation of thyrocytes
Normal thyroid tissues adjacent to thyroid follicular adenomas were taken from surgical specimens. Thyroid tissues were also obtained from Graves' disease patients who were euthyroid at the time of subtotal thyroidectomy. The methods used to prepare the thyrocytes have been reported elsewhere in detail (12, 13 (Fig. 3A) . Thus, the addition of indomethacin to thyrocyte cultures did not enhance the thyrocyte proliferative response to endothe¬ lin. The proliferative response of the thyrocytes was unaffected by the addition of indomethacin alone. The growth-promoting activity of such cytokines as fibroblast growth factors (FGF) has been shown to be altered by the addition of heparin (15) , heparin enhancing the growth-promoting activity of acidic FGF but inhibiting that of basic FGF (15) . To determine whether heparin affected the endothelin-induced thyrocyte proliferation, we cultured normal thyrocytes with various amounts of heparin in the presence of 10~8 mol/1 endothelin. Heparin did not affect endothelin-induced thyrocyte proliferation (Fig. 3B) (Fig. 4) . Endothelin alone significantly increased the thyrocyte proliferation. Moreover, when thyrocytes were cultured with both rIL-l/J and endothelin, the cytokines had an additive effect on thyrocyte prolifera¬ tion (Fig. 4) . (17) and stimulation of aldosterone biosynthesis (18) . We (14) . Moreover, thyrocytes produced significant amounts of prosta¬ glandin E2 in response to rIL-lß (14) . Because endogenous and exogenous prostaglandins inhibit cell proliferation (20) , the cyclooxygenase inhibitor indo¬ methacin is able to enhance rfL-1/'-stimulated thyrocyte proliferation. These results suggest that the direct stimulatory effect of IL-1 on human thyrocyte growth may be counterbalanced by an autocrine inhibitory loop involving thyrocyte PG synthesis (14) . Our (14) . The 
